Taro Pharma plans shares repurchase worth $250 million EP News Bureau Mar 17, 2016 The repurchase authorisation enables it to purchase it's ordinary shares from time to time through open market purchases
Alkem Laboratories gets SEBI’s nod for IPO Usha Sharma Oct 27, 2015 As per the draft papers, the company will come out with a public offer of up to 12,853,442 equity shares
